It pays to be the dominant player in a niche industry, and this certainly holds true for IDEXX Laboratories (NASDAQ:IDXX). Over the past year, IDXX's stock has soared by 105%, driven by a number of
IDEXX Laboratories: This Moat-Worthy Name Is Poised To Grow
Summary
- IDEXX Laboratories is an industry leader in the field of veterinary health care, and has seen robust growth over the years.
- It's poised for continued growth, as it continues to scale its revenue base in the current favorable environment for pet adoptions.
- I also highlight the valuation, balance sheet, and risks worth considering.
I am Gen Alpha. I have more than 14 years of investment experience, and an MBA in Finance. I focus on stocks that are more defensive in nature, with a medium- to long-term horizon.
I provide high-yield, dividend growth investment ideas in the investing group
. The group helps investors achieve dependable monthly income, portfolio diversification, and inflation hedging. It provides investment research on REITs, ETFs, closed-end funds, preferreds, and dividend champions across asset classes. It offers income-focused portfolios targeting dividend yields up to 10%.
.
Analyst’s Disclosure:I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
This article is for informational purposes and does not constitute as financial advice. Readers are encouraged and expected to perform due diligence and draw their own conclusions prior to making any investment decisions.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.